secwatch.observer — SEC 8-K summary
======================================

Issuer:     CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CIK:        0001870404
Form:       8-K
Filed at:   2025-04-25T23:59:59+00:00
Accession:  0001213900-25-035535
Event type: other_material
Sentiment:  positive
Materiality: 0.50
Item codes: 5.03, 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CERo files Series D Preferred Stock designation; regains Nasdaq bid price compliance
--------------------------------------------------------------------------------

- Filed Certificate of Designations for Series D convertible preferred stock effective April 22, 2025, part of previously reported securities purchase agreement.
- April 24 closing price was $1.11, ending 26 consecutive trading days below $1.00.
- No longer imminent risk of failing Nasdaq's minimum bid price requirement, though future risk remains.
- Corporate presentation dated April 2025 furnished; exhibit contains no new specific operational or financial data.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025035535/0001213900-25-035535-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1870404/000121390025035535/ea0239321-8k_cero.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-035535

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer